Results 11 to 20 of about 128,493 (313)
Frontiers in Cardiovascular Medicine, 2022 BackgroundAlthough the predictive value of galectin-3 for heart failure with preserved ejection fraction has been demonstrated, the diagnostic value remains unclear.
Jing Jiang +5 more
doaj +1 more source
Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 The findings of randomized trials of neurohormonal modulation have been neutral in heart failure with preserved ejection fraction and consistently positive in heart failure with reduced ejection.
Rohan Samson, Thierry H. Le Jemtel
doaj +1 more source
Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
Frontiers in Physiology, 2022 Heart failure with preserved ejection fraction is a growing epidemic and accounts for half of all patients with heart failure. Increasing prevalence, morbidity, and clinical inertia have spurred a rethinking of the pathophysiology of heart failure with ...
Aneesh Dhore-patil +7 more
doaj +1 more source
Anatolian Journal of Cardiology, 2023 Background: Heart failure with preserved ejection fraction is a complex and heterogeneous clinical syndrome, poses significant diagnostic challenges.
Gurbet Özge Mert +19 more
doaj +1 more source
Frontiers in Immunology, 2022 The incidence of heart failure with preserved ejection fraction is increasing in patients with obesity, diabetes, hypertension, and in the aging population. However, there is a lack of adequate clinical treatment.
Chenyu Li +5 more
doaj +1 more source
Терапевтический архив, 2023 Heart failure with mildly reduced ejection fraction and heart failure with preserved ejection fraction are associated with significant morbidity and mortality, as well as growing economic burden.
Igor V. Zhirov +2 more
doaj +1 more source
Managing heart failure with preserved ejection fraction [PDF]
Annals of Translational Medicine, 2020 Heart failure with preserved ejection fraction (HFpEF) is increasing in prevalence as the general population ages. Poorly managed heart failure symptoms of decompensated HFpEF is one of the most common reasons for prolonged hospital admission. The high rate of morbidity and mortality associated with HFpEF is compounded by a poor understanding of the ...
Davidson, Alexander +3 more
openaire +3 more sources
Heart Failure With Preserved Ejection Fraction: Defining Phenotypes [PDF]
Journal of Cardiac Failure, 2020 Heart failure with preserved ejection (HFpEF) has been increasingly recognized as an epidemic and various phenotypes have now been suggested.
Donal, Erwan +2 more
openaire +3 more sources
Heart failure with preserved ejection fraction. [PDF]
Journal of geriatric cardiology : JGC, 2013 Progressive aging of the population and prolongation of life expectancy have led to the rising prevalence of heart failure (HF). Despite the improvements in medical therapy, the mortality rate of this condition has remained unacceptably high, becoming the primary cause of death in the elderly population.
Whalley, Gillian, Rigolli, Marzia
openaire +5 more sources
Heart Failure With Preserved Ejection Fraction
Journal of Osteopathic Medicine, 2015 Abstract Heart failure with preserved ejection fraction (HFpEF) is a complex clinical condition. Initially called diastolic heart failure, it soon became clear that this condition is more than the opposite side of systolic heart failure. It is increasingly prevalent and lethal.
Felix J, Rogers +3 more
openaire +3 more sources